SPT-300 clinical trials

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

This study is testing a new medication called GlyphAllo for adults with depression, with or without anxiety. It's a key step to see if it's safe and helps improve mood and reduce symptoms. Half the participants will receive the new medication and half will receive a dummy pill.